Biotech Firm OKYO Pharma Closes US$2.5 Million IPO

Biotech firm OKYO Pharma Limited (Nasdaq: OKYO) closed on Thursday its initial public offering on the Nasdaq Capital Market. The firm was able to raise approximately US$2.5 million in its debut on the big board.

The offering consisted of 625,000 American depository shares at US$4.00 per share. The company’s shares are trading under the symbol “OKYO”.

Proceeds of the offering are intended for advancing the firm’s drug candidate OK-101 to filing an investigative new drug application, funding the drug’s phase 2 clinical trial, and for working capital and other general corporate purposes.

ThinkEquity acted as the sole bookrunner for the said offering.

The London-based life sciences company is focused on treating patients suffering from inflammatory eye diseases and ocular pain. It is presently developing its lead preclinical product candidate OK-101 to treat dry-eye disease.

OKYO Pharma last traded at US$3.00 on the Nasdaq.


Information for this briefing was found via Edgar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Baselode Energy To Acquire Forum Energy: The Merger Of Equals Deal

TriStar Gold: The Revised Castelo de Sonhos Prefeasibility Study

Gold is Up 30%, But the Real Bull Market is Only Starting Now! | Adrian Day

Recommended

ESGold To Expand Mine Building At Montauban In Advance Of Gold & Silver Production

Goliath Resources Expands 2025 Drill Program To 60,000 Metres

Related News

Solar Car Maker Sono Motors Prices US$150 Million IPO

Electric solar car manufacturer Sono Motors (Nasdaq: SEV) started publicly trading on the Nasdaq Global...

Wednesday, November 17, 2021, 03:34:00 PM

Asset Manager TPG Prices US$1 Billion IPO

Private equity firm TPG Inc. (Nasdaq: TPG) began trading on the Nasdaq Global Select Market...

Thursday, January 13, 2022, 02:22:00 PM

Healthcare SPAC DTRT Health Acquisition Prices US$200 Million IPO

Blank check company DTRT Health Acquisition Corp. (Nasdaq: DTRTU) went public today on the Nasdaq...

Thursday, September 2, 2021, 12:57:00 PM

Gaming SPAC UTA Acquisition Prices US$200 Million IPO

Special purpose acquisition company UTA Acquisition Corporation (Nasdaq: UTAAU) started trading publicly on the Nasdaq...

Thursday, December 2, 2021, 02:17:00 PM

Colombian Mining Firm Mineros Closes US$20 Million IPO, Starts Trading On TSX

Latin American gold mining company Mineros S.A. (TSX: MSA) closed on Friday its initial public...

Monday, November 22, 2021, 02:17:00 PM